Exploring how different amounts of physical activity affect arthritis symptoms
Examination of the Dose Response Relationship Between Physical Activity and Arthritis-Attributable Outcomes
This study is looking at how different amounts of exercise can help adults with arthritis feel better, and it’s for anyone who wants to find out how much activity they need to improve their pain and daily life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11046169 on NIH RePORTER |
What this research studies
This research investigates how varying doses of moderate-to-vigorous physical activity (MVPA) impact outcomes related to arthritis in adults. It aims to determine the minimal amount of activity needed to improve symptoms such as pain, physical function, and quality of life. Participants will engage in different levels of physical activity (45, 90, or 150 minutes per week) and report their experiences over a period of 6 to 12 months. The study seeks to provide tailored recommendations for those struggling to meet standard activity guidelines.
Who could benefit from this research
Good fit: Ideal candidates are adults diagnosed with arthritis who are currently not meeting physical activity guidelines and are seeking ways to manage their symptoms.
Not a fit: Patients with severe mobility limitations or those unable to engage in any physical activity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help identify achievable physical activity goals that improve arthritis symptoms and overall well-being.
How similar studies have performed: Previous research has shown that physical activity can improve arthritis symptoms, but this study aims to refine the understanding of the specific doses needed for optimal outcomes.
Where this research is happening
Columbia, United States
- University of South Carolina at Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Pellegrini, Christine Ann — University of South Carolina at Columbia
- Study coordinator: Pellegrini, Christine Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.